Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 7
2021 32
2022 28
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Duration of immune protection of SARS-CoV-2 natural infection against reinfection.
Chemaitelly H, Nagelkerke N, Ayoub HH, Coyle P, Tang P, Yassine HM, Al-Khatib HA, Smatti MK, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. J Travel Med. 2022 Dec 27;29(8):taac109. doi: 10.1093/jtm/taac109. J Travel Med. 2022. PMID: 36179099 Free PMC article.
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections.
Qassim SH, Hasan MR, Tang P, Chemaitelly H, Ayoub HH, Yassine HM, Al-Khatib HA, Smatti MK, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Al-Khal A, Coyle P, Gillani I, Kaleeckal AH, Shaik RM, Latif AN, Al-Kuwari E, Jeremijenko A, Butt AA, Bertollini R, Al-Romaihi HE, Al-Thani MH, Abu-Raddad LJ. Qassim SH, et al. Front Immunol. 2022 Sep 13;13:984784. doi: 10.3389/fimmu.2022.984784. eCollection 2022. Front Immunol. 2022. PMID: 36177014 Free PMC article.
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage.
Chemaitelly H, Ayoub HH, Coyle P, Tang P, Yassine HM, Al-Khatib HA, Smatti MK, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. Nat Commun. 2022 Aug 9;13(1):4675. doi: 10.1038/s41467-022-32363-4. Nat Commun. 2022. PMID: 35945213 Free PMC article.
Comparative COVID-19 Vaccine Effectiveness Over Time in Veterans.
Mayr FB, Talisa VB, Shaikh OS, Omer SB, Butt AA, Yende S. Mayr FB, et al. Open Forum Infect Dis. 2022 Jun 24;9(7):ofac311. doi: 10.1093/ofid/ofac311. eCollection 2022 Jul. Open Forum Infect Dis. 2022. PMID: 35880233 Free PMC article.
COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar.
Abu-Raddad LJ, Dargham S, Chemaitelly H, Coyle P, Al Kanaani Z, Al Kuwari E, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R. Abu-Raddad LJ, et al. PLoS One. 2022 Jul 19;17(7):e0271324. doi: 10.1371/journal.pone.0271324. eCollection 2022. PLoS One. 2022. PMID: 35853026 Free PMC article.
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
Altarawneh HN, Chemaitelly H, Ayoub HH, Tang P, Hasan MR, Yassine HM, Al-Khatib HA, Smatti MK, Coyle P, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Altarawneh HN, et al. N Engl J Med. 2022 Jul 7;387(1):21-34. doi: 10.1056/NEJMoa2203965. Epub 2022 Jun 15. N Engl J Med. 2022. PMID: 35704396 Free PMC article.
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar.
Chemaitelly H, Ayoub HH, AlMukdad S, Coyle P, Tang P, Yassine HM, Al-Khatib HA, Smatti MK, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. Nat Commun. 2022 Jun 2;13(1):3082. doi: 10.1038/s41467-022-30895-3. Nat Commun. 2022. PMID: 35654888 Free PMC article.
Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections.
Qassim SH, Chemaitelly H, Ayoub HH, AlMukdad S, Tang P, Hasan MR, Yassine HM, Al-Khatib HA, Smatti MK, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Al-Khal A, Coyle P, Kaleeckal AH, Shaik RM, Latif AN, Al-Kuwari E, Jeremijenko A, Butt AA, Bertollini R, Al-Romaihi HE, Al-Thani MH, Abu-Raddad LJ. Qassim SH, et al. J Travel Med. 2022 Sep 17;29(6):taac068. doi: 10.1093/jtm/taac068. J Travel Med. 2022. PMID: 35639932 Free PMC article. No abstract available.
Predictors of mortality and morbidity in critically ill COVID-19 patients: An experience from a low mortality country.
Khatib MY, Ananthegowda DC, Elshafei MS, El-Zeer H, Abdaljawad WI, Shaheen MA, Ibrahim AS, Abujaber AA, Soliman AA, Mohamed AS, Al-Wraidat M, Ahmed A, Nashwan AJ, Saad MO, Butt AA, Al-Maslamani MA, Al-Mohammed A. Khatib MY, et al. Health Sci Rep. 2022 May 17;5(3):e542. doi: 10.1002/hsr2.542. eCollection 2022 May. Health Sci Rep. 2022. PMID: 35601034 Free PMC article.
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
Butt AA, Dargham SR, Loka S, Shaik RM, Chemaitelly H, Tang P, Hasan MR, Coyle PV, Yassine HM, Al-Khatib HA, Smatti MK, Kaleeckal AH, Latif AN, Zaqout A, Almaslamani MA, Al Khal A, Bertollini R, Abou-Samra AB, Abu-Raddad LJ. Butt AA, et al. Clin Infect Dis. 2022 Aug 24;75(1):e361-e367. doi: 10.1093/cid/ciac275. Clin Infect Dis. 2022. PMID: 35404391 Free PMC article.
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
Abu-Raddad LJ, Chemaitelly H, Ayoub HH, AlMukdad S, Yassine HM, Al-Khatib HA, Smatti MK, Tang P, Hasan MR, Coyle P, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R. Abu-Raddad LJ, et al. N Engl J Med. 2022 May 12;386(19):1804-1816. doi: 10.1056/NEJMoa2200797. Epub 2022 Mar 9. N Engl J Med. 2022. PMID: 35263534 Free PMC article.
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.
Altarawneh HN, Chemaitelly H, Hasan MR, Ayoub HH, Qassim S, AlMukdad S, Coyle P, Yassine HM, Al-Khatib HA, Benslimane FM, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Tang P, Abu-Raddad LJ. Altarawneh HN, et al. N Engl J Med. 2022 Mar 31;386(13):1288-1290. doi: 10.1056/NEJMc2200133. Epub 2022 Feb 9. N Engl J Med. 2022. PMID: 35139269 Free PMC article. No abstract available.
Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar's experience.
Bsat R, Chemaitelly H, Coyle P, Tang P, Hasan MR, Al Kanaani Z, Al Kuwari E, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Nasrallah GK, Benslimane FM, Al Khatib HA, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R, Abu-Raddad LJ, Ayoub HH. Bsat R, et al. J Glob Health. 2022 Feb 5;12:05004. doi: 10.7189/jogh.12.05004. eCollection 2022. J Glob Health. 2022. PMID: 35136602 Free PMC article.
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections.
Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Tang P, Coyle P, Hasan MR, Yassine HM, Benslimane FM, Al-Khatib HA, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Khal A, Al-Thani MH, Bertollini R. Abu-Raddad LJ, et al. Nat Commun. 2022 Jan 27;13(1):532. doi: 10.1038/s41467-022-28199-7. Nat Commun. 2022. PMID: 35087035 Free PMC article.
Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar.
Abu-Raddad LJ, Chemaitelly H, Bertollini R; National Study Group for COVID-19 Vaccination. Abu-Raddad LJ, et al. N Engl J Med. 2022 Mar 17;386(11):1091-1093. doi: 10.1056/NEJMc2119432. Epub 2022 Jan 26. N Engl J Med. 2022. PMID: 35081294 Free PMC article. No abstract available.
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.
Abu-Raddad LJ, Chemaitelly H, Bertollini R; National Study Group for COVID-19 Vaccination. Abu-Raddad LJ, et al. N Engl J Med. 2022 Feb 24;386(8):799-800. doi: 10.1056/NEJMc2117933. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045222 Free PMC article. No abstract available.
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Coyle P, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, Tang P, Al Kanaani Z, Al Kuwari E, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R. Abu-Raddad LJ, et al. PLoS Med. 2021 Dec 16;18(12):e1003879. doi: 10.1371/journal.pmed.1003879. eCollection 2021 Dec. PLoS Med. 2021. PMID: 34914711 Free PMC article.
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar.
Tang P, Hasan MR, Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, AlMukdad S, Coyle P, Ayoub HH, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Al Romaihi HE, Butt AA, Al-Thani MH, Al Khal A, Bertollini R, Abu-Raddad LJ. Tang P, et al. Nat Med. 2021 Dec;27(12):2136-2143. doi: 10.1038/s41591-021-01583-4. Epub 2021 Nov 2. Nat Med. 2021. PMID: 34728831
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Yassine HM, Benslimane FM, Al Khatib HA, Tang P, Hasan MR, Coyle P, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Butt AA, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R. Abu-Raddad LJ, et al. JAMA. 2021 Nov 16;326(19):1930-1939. doi: 10.1001/jama.2021.19623. JAMA. 2021. PMID: 34724027 Free PMC article.
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant.
Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Yassine HM, Benslimane FM, Al Khatib HA, Tang P, Hasan MR, Coyle P, AlMukdad S, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Butt AA, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R. Abu-Raddad LJ, et al. Clin Infect Dis. 2022 Aug 24;75(1):e1188-e1191. doi: 10.1093/cid/ciab909. Clin Infect Dis. 2022. PMID: 34657152 Free PMC article.
Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.
Alishaq M, Nafady-Hego H, Jeremijenko A, Al Ajmi JA, Elgendy M, Vinoy S, Fareh SB, Veronica Plaatjies J, Nooh M, Alanzi N, Kaleeckal AH, Latif AN, Coyle P, Elgendy H, Abou-Samra AB, Butt AA. Alishaq M, et al. PLoS One. 2021 Oct 15;16(10):e0258820. doi: 10.1371/journal.pone.0258820. eCollection 2021. PLoS One. 2021. PMID: 34653228 Free PMC article.
SARS-CoV-2 infection rates in air passengers arriving in Qatar.
Butt AA, Al-Halabi AM, Ghazouani H, Rhouma MBH, Ayoub HH, Masoodi NA, Borham AM, Hommos AA, Bertollini R, Chemaitelly H, Abu Raddad LJ, Abou-Samra AB. Butt AA, et al. J Travel Med. 2021 Dec 29;28(8):taab163. doi: 10.1093/jtm/taab163. J Travel Med. 2021. PMID: 34622294 Free PMC article.
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
Chemaitelly H, Tang P, Hasan MR, AlMukdad S, Yassine HM, Benslimane FM, Al Khatib HA, Coyle P, Ayoub HH, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Al Romaihi HE, Butt AA, Al-Thani MH, Al Khal A, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. N Engl J Med. 2021 Dec 9;385(24):e83. doi: 10.1056/NEJMoa2114114. Epub 2021 Oct 6. N Engl J Med. 2021. PMID: 34614327 Free PMC article.
Prevalence and risk factors for SARS-CoV-2 infection and seroprevalence among clinical and non-clinical staff in a national healthcare system.
Alishaq M, Jeremijenko A, Al-Kanaani Z, Nafady-Hego H, Jboor DH, Saba R, Al-Ajmi J, Alansari NA, Thomas AG, Fareh SB, Vinoy S, Nooh M, Alanzi N, Abou-Samra AB, Butt AA. Alishaq M, et al. PLoS One. 2021 Sep 30;16(9):e0257845. doi: 10.1371/journal.pone.0257845. eCollection 2021. PLoS One. 2021. PMID: 34591920 Free PMC article.
SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar.
Seedat S, Chemaitelly H, Ayoub HH, Makhoul M, Mumtaz GR, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R, Abu-Raddad LJ. Seedat S, et al. Sci Rep. 2021 Sep 14;11(1):18182. doi: 10.1038/s41598-021-97606-8. Sci Rep. 2021. PMID: 34521903 Free PMC article.
SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar.
Al-Thani MH, Farag E, Bertollini R, Al Romaihi HE, Abdeen S, Abdelkarim A, Daraan F, Elhaj Ismail AIH, Mostafa N, Sahl M, Suliman J, Tayar E, Kasem HA, Agsalog MJA, Akkarathodiyil BK, Alkhalaf AA, Alakshar MMMH, Al-Qahtani AAAH, Al-Shedifat MHA, Ansari A, Ataalla AA, Chougule S, Gopinathan AKKV, Poolakundan FJ, Ranbhise SU, Saefan SMA, Thaivalappil MM, Thoyalil AS, Umar IM, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Yassine HM, Nasrallah GK, Al Kuwari MG, Chaghoury O, Chemaitelly H, Abu-Raddad LJ; Craft and Manual Workers Seroprevalence Study Group. Al-Thani MH, et al. Open Forum Infect Dis. 2021 May 2;8(8):ofab221. doi: 10.1093/ofid/ofab221. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34458388 Free PMC article.
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination.
Butt AA, Nafady-Hego H, Chemaitelly H, Abou-Samra AB, Khal AA, Coyle PV, Kanaani ZA, Kaleeckal AH, Latif AN, Masalmani YA, Bertollini R, Raddad LJA. Butt AA, et al. Int J Infect Dis. 2021 Sep;110:353-358. doi: 10.1016/j.ijid.2021.08.008. Epub 2021 Aug 8. Int J Infect Dis. 2021. PMID: 34375762 Free PMC article.
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar.
Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, Tang P, Hasan MR, Malek JA, Coyle P, Ayoub HH, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Butt AA, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. Nat Med. 2021 Sep;27(9):1614-1621. doi: 10.1038/s41591-021-01446-y. Epub 2021 Jul 9. Nat Med. 2021. PMID: 34244681
Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.
Ayoub HH, Chemaitelly H, Makhoul M, Al Kanaani Z, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R, Al Khal A, Abu-Raddad LJ. Ayoub HH, et al. BMJ Innov. 2021 Apr;7(2):327-336. doi: 10.1136/bmjinnov-2021-000677. Epub 2021 Mar 31. BMJ Innov. 2021. PMID: 34192020
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals.
Coyle PV, Chemaitelly H, Ben Hadj Kacem MA, Abdulla Al Molawi NH, El Kahlout RA, Gilliani I, Younes N, Al Anssari GAAA, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R, Abu-Raddad LJ. Coyle PV, et al. iScience. 2021 Jun 25;24(6):102646. doi: 10.1016/j.isci.2021.102646. Epub 2021 May 24. iScience. 2021. PMID: 34056566 Free PMC article.
Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses.
Abu-Raddad LJ, Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, Tang P, Malek JA, Coyle P, Ayoub HH, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Butt AA, Bertollini R. Abu-Raddad LJ, et al. J Travel Med. 2021 Oct 11;28(7):taab083. doi: 10.1093/jtm/taab083. J Travel Med. 2021. PMID: 34050372 Free PMC article. No abstract available.
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy.
Abu-Raddad LJ, Chemaitelly H, Coyle P, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, Ayoub HH, Al Kanaani Z, Al Kuwari E, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R. Abu-Raddad LJ, et al. EClinicalMedicine. 2021 May;35:100861. doi: 10.1016/j.eclinm.2021.100861. Epub 2021 Apr 28. EClinicalMedicine. 2021. PMID: 33937733 Free PMC article.
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.
Jeremijenko A, Chemaitelly H, Ayoub HH, Alishaq M, Abou-Samra AB, Al Ajmi JAAA, Al Ansari NAA, Al Kanaani Z, Al Khal A, Al Kuwari E, Al-Mohammed A, Al Molawi NHA, Al Naomi HM, Butt AA, Coyle P, El Kahlout RA, Gillani I, Kaleeckal AH, Masoodi NA, Thomas AG, Nafady-Hego H, Latif AN, Shaik RM, Younes NBM, Rahim HFA, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R, Abu-Raddad LJ. Jeremijenko A, et al. Emerg Infect Dis. 2021 May;27(5):1343-1352. doi: 10.3201/eid2705.204365. Emerg Infect Dis. 2021. PMID: 33900174 Free PMC article.
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic.
Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Owen RC, Rahim HFA, Al Abdulla SA, Al Kuwari MG, Kandy MC, Saeb H, Ahmed SNN, Al Romaihi HE, Bansal D, Dalton L, Al-Thani MH, Bertollini R. Abu-Raddad LJ, et al. Sci Rep. 2021 Mar 18;11(1):6233. doi: 10.1038/s41598-021-85428-7. Sci Rep. 2021. PMID: 33737535 Free PMC article.
SARS-CoV-2 infection in mortuary and cemetery workers.
Alishaq M, Jeremijenko A, Nafady-Hego H, Al Ajmi JA, Elgendy M, Fadel RAA, Thomas AG, Alahmed MAA, Ammar A, Bensaad M, Al-Barghouthi B, Coyle P, Elgendy H, Abou-Samra AB, Butt AA. Alishaq M, et al. Int J Infect Dis. 2021 Apr;105:621-625. doi: 10.1016/j.ijid.2021.03.012. Epub 2021 Mar 9. Int J Infect Dis. 2021. PMID: 33711522 Free article.
Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19.
Ayoub HH, Chemaitelly H, Seedat S, Makhoul M, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Rahim HA, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R, Abu Raddad LJ. Ayoub HH, et al. J Glob Health. 2021 Jan 16;11:05005. doi: 10.7189/jogh.11.05005. J Glob Health. 2021. PMID: 33643638 Free PMC article.
Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months.
Abu-Raddad LJ, Chemaitelly H, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R. Abu-Raddad LJ, et al. Infect Genet Evol. 2021 Mar;88:104684. doi: 10.1016/j.meegid.2020.104684. Epub 2020 Dec 24. Infect Genet Evol. 2021. PMID: 33352320 Free PMC article.
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
Abu-Raddad LJ, Chemaitelly H, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, Ayoub HH, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R. Abu-Raddad LJ, et al. Clin Infect Dis. 2021 Oct 5;73(7):e1830-e1840. doi: 10.1093/cid/ciaa1846. Clin Infect Dis. 2021. PMID: 33315061 Free PMC article.
Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February-18 April 2020.
Al Kuwari HM, Abdul Rahim HF, Abu-Raddad LJ, Abou-Samra AB, Al Kanaani Z, Al Khal A, Al Kuwari E, Al Marri S, Al Masalmani M, Al Romaihi HE, Al Thani MH, Coyle PV, Latif AN, Owen R, Bertollini R, Butt AA. Al Kuwari HM, et al. BMJ Open. 2020 Oct 7;10(10):e040428. doi: 10.1136/bmjopen-2020-040428. BMJ Open. 2020. PMID: 33033033 Free PMC article.